Dyne Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 02/06/2025 | 8.02 M | $188.94 M | -0.01% | 7.95% |
FMR LLC | 02/13/2025 | 8.00 M | $188.41 M | -11.41% | 7.93% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 7.95 M | $187.29 M | 1.99% | 7.88% |
JANUS HENDERSON GROUP PLC | 02/14/2025 | 7.38 M | $173.81 M | 8.31% | 7.31% |
VANGUARD GROUP INC | 02/11/2025 | 6.70 M | $157.94 M | -2.33% | 6.65% |
RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 6.38 M | $150.34 M | 0.00% | 6.33% |
FCPM III SERVICES B.V. | 02/14/2025 | 5.46 M | $128.70 M | -8.25% | 5.42% |
RTW INVESTMENTS, LP | 02/14/2025 | 5.22 M | $122.95 M | -23.47% | 5.17% |
STATE STREET CORP | 02/14/2025 | 3.72 M | $87.58 M | 2.07% | 3.68% |
TCG CROSSOVER MANAGEMENT, LLC | 02/14/2025 | 2.65 M | $62.44 M | 0.00% | 2.63% |
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 2.40 M | $56.60 M | -8.87% | 2.38% |
HOLOCENE ADVISORS, LP | 02/14/2025 | 2.35 M | $55.32 M | 18.44% | 2.33% |
VR ADVISER, LLC | 02/14/2025 | 2.17 M | $51.22 M | 0.00% | 2.15% |
DEEP TRACK CAPITAL, LP | 02/14/2025 | 2.00 M | $47.12 M | -39.06% | 1.98% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 1.95 M | $45.94 M | -18.85% | 1.93% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.89 M | $44.48 M | 1.50% | 1.87% |
JEFFERIES FINANCIAL GROUP INC. | 02/27/2025 | 1.80 M | $42.41 M | 100.00% | 1.78% |
SIREN, L.L.C. | 02/14/2025 | 1.35 M | $31.75 M | 18.75% | 1.34% |
FRANKLIN RESOURCES INC | 02/12/2025 | 1.32 M | $31.19 M | -1.39% | 1.31% |
ORBIMED ADVISORS LLC | 02/14/2025 | 1.23 M | $28.91 M | 73.22% | 1.22% |
JENNISON ASSOCIATES LLC | 01/24/2025 | 1.21 M | $28.55 M | -10.03% | 1.20% |
VIVO CAPITAL, LLC | 02/13/2025 | 1.11 M | $26.27 M | 0.00% | 1.11% |
SOFINNOVA INVESTMENTS, INC. | 02/14/2025 | 1.07 M | $25.24 M | 38.78% | 1.06% |
FEDERATED HERMES, INC. | 02/13/2025 | 1.06 M | $24.89 M | -13.22% | 1.05% |
ARMISTICE CAPITAL, LLC | 02/14/2025 | 964,518 | $22.72 M | -16.51% | 0.96% |
NORGES BANK | 02/12/2025 | 950,104 | $22.38 M | 100.00% | 0.94% |
ARROWMARK COLORADO HOLDINGS LLC | 02/14/2025 | 932,231 | $21.96 M | 3.56% | 0.92% |
POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 924,681 | $21.79 M | 802.30% | 0.92% |
MAN GROUP PLC | 02/14/2025 | 746,463 | $17.59 M | 3.87% | 0.74% |
MPM ASSET MANAGEMENT LLC | 02/14/2025 | 682,376 | $16.08 M | 0.00% | 0.68% |
BRAIDWELL LP | 02/14/2025 | 681,182 | $16.05 M | 100.00% | 0.68% |
BAKER BROS. ADVISORS LP | 02/14/2025 | 672,096 | $15.83 M | 0.00% | 0.67% |
OCTAGON CAPITAL ADVISORS LP | 02/14/2025 | 668,000 | $15.74 M | 154.26% | 0.66% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 667,452 | $15.73 M | 2.90% | 0.66% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 628,703 | $14.81 M | -6.23% | 0.62% |
WOODLINE PARTNERS LP | 02/14/2025 | 573,957 | $13.52 M | -41.28% | 0.57% |
ECOR1 CAPITAL, LLC | 02/14/2025 | 555,644 | $13.09 M | 0.00% | 0.55% |
PERCEPTIVE ADVISORS LLC | 02/14/2025 | 543,277 | $12.80 M | -24.35% | 0.54% |
UBS GROUP AG | 02/14/2025 | 540,112 | $12.73 M | -13.68% | 0.54% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 474,528 | $11.18 M | 2.93% | 0.47% |
LOGOS GLOBAL MANAGEMENT LP | 02/14/2025 | 450,000 | $10.60 M | 181.25% | 0.45% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/14/2025 | 435,653 | $10.26 M | 0.00% | 0.43% |
FIRST LIGHT ASSET MANAGEMENT, LLC | 02/14/2025 | 420,431 | $9.91 M | -66.56% | 0.42% |
VIDA VENTURES ADVISORS, LLC | 01/21/2025 | 407,499 | $9.60 M | 0.00% | 0.40% |
CANDRIAM S.C.A. | 02/07/2025 | 401,395 | $9.46 M | 2.67% | 0.40% |
EVENTIDE ASSET MANAGEMENT, LLC | 02/14/2025 | 332,277 | $7.83 M | 0.00% | 0.33% |
PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 323,552 | $7.62 M | 6.19% | 0.32% |
WASATCH ADVISORS LP | 02/13/2025 | 320,626 | $7.55 M | -1.07% | 0.32% |
ENSIGN PEAK ADVISORS, INC | 02/14/2025 | 315,602 | $7.44 M | 0.91% | 0.31% |
FRONTIER CAPITAL MANAGEMENT CO LLC | 02/14/2025 | 298,052 | $7.02 M | 100.00% | 0.30% |
Dyne Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 239 institutional investors and hedge funds held shares of Dyne Therapeutics, Inc.. The most heavily invested institutionals were:
Atlas Venture Life Science Advisors, LLC: 8.02 M
FMR LLC: 8 M
BlackRock Funding, Inc. /DE: 7.95 M
JANUS HENDERSON GROUP PLC: 7.38 M
VANGUARD GROUP INC: 6.7 M
RA CAPITAL MANAGEMENT, L.P.: 6.38 M
110.62% of Dyne Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 120.13 M shares in the last 24 months. This purchase volume represents approximately $2.95 B in transactions.